93. 原発性胆汁性胆管炎［原発性胆汁性肝硬変 (~2017.3)］
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-UMIN000031384||2018/03/16||20/02/2018||Efficacy and safety of Denosumab treatment for osteoporosis in patients with primary biliary cholangitis; a randomized controlled trial with zoledronic acid (DELTA Study)||PBC patients with osteoporosis||Denosumab group|
(60 mg Denosumab is administered subcutaneously every 6 month)
Zoledronic acid group
(5 mg Zoledronic acid is administered intravenously every 12 month)
|Tokai University School of Medicine||Ministry of Health, Labour and Welfare||Recruiting||20years-old||89years-old||Male and Female||80||Not selected||Japan|